GLYCOCONJUGATE JOURNAL

Scope & Guideline

Pioneering Research in Glycoconjugate Science

Introduction

Immerse yourself in the scholarly insights of GLYCOCONJUGATE JOURNAL with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0282-0080
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1984 to 2024
AbbreviationGLYCOCONJUGATE J / Glycoconjugate J.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The Glycoconjugate Journal focuses on the multifaceted roles of glycoconjugates in biology and medicine, emphasizing their significance in disease mechanisms, therapeutic applications, and biotechnological advancements. The journal aims to provide a platform for innovative research that explores the structural and functional diversity of glycoconjugates, as well as their interactions with various biological systems.
  1. Glycobiology and Disease Mechanisms:
    Research exploring the roles of glycoconjugates in various diseases, including cancer, neurodegeneration, and metabolic disorders, highlighting their potential as biomarkers and therapeutic targets.
  2. Glycoconjugate Synthesis and Characterization:
    Studies focused on the chemical synthesis, enzymatic modifications, and structural characterization of glycoconjugates, providing insights into their functional properties and applications.
  3. Lectin and Glycan Interactions:
    Investigations into the interactions between lectins and glycans, which are crucial for understanding cell signaling, immune responses, and pathogen recognition.
  4. Glycoconjugate Vaccines and Therapeutics:
    Research related to the development of glycoconjugate vaccines and therapeutics, addressing their design, immunogenicity, and clinical applications in infectious diseases and cancer.
  5. Glycan Profiling and Analytical Techniques:
    Advancements in analytical methods for glycan profiling, including mass spectrometry and chromatography, to enhance the understanding of glycosylation patterns in health and disease.
The Glycoconjugate Journal is currently witnessing a rise in interest in several emerging themes, reflecting the dynamic nature of glycobiology and its applications in health and disease. These trends indicate a growing recognition of the importance of glycoconjugates in various biological contexts.
  1. Glycans in Cancer Immunology:
    There is an increasing focus on the role of glycans in cancer immunology, particularly in understanding how glycosylation affects tumor immune evasion and therapy resistance, highlighting glycans as potential targets for immunotherapy.
  2. Therapeutic Applications of Glycans:
    Research exploring the therapeutic applications of glycans, including their use in drug delivery systems and as therapeutic agents, is gaining traction, showcasing the translational potential of glycoconjugate research.
  3. Microbiome-Glycan Interactions:
    Emerging studies are investigating the interactions between gut microbiota and glycans, with implications for understanding metabolic health, immunity, and disease, reflecting a holistic view of glycan functions in human health.
  4. Advanced Glycoconjugate Vaccines:
    The development of novel glycoconjugate vaccines, particularly in response to infectious diseases like COVID-19, is trending, emphasizing the importance of glycoconjugates in vaccine design and immune response.
  5. Glycobiology in Neurodegenerative Diseases:
    Research linking glycobiology to neurodegenerative diseases, including the role of glycans in neuroinflammation and neuroprotection, is emerging as a significant area of interest, underscoring the relevance of glycoconjugates in brain health.

Declining or Waning

While the journal has consistently published impactful research, certain themes appear to be declining in prominence. This shift may reflect evolving research interests within the field of glycobiology and changing technological landscapes.
  1. Traditional Glycobiology Studies:
    There is a noticeable decrease in publications focusing solely on classical glycobiology topics without integrative approaches, as researchers increasingly explore interdisciplinary themes that combine glycobiology with other biological sciences.
  2. Basic Enzymatic Functions of Glycosyltransferases:
    Research dedicated to the basic enzymatic functions of glycosyltransferases seems to be waning, possibly due to a shift towards more applied research that investigates their roles in complex biological systems rather than isolated enzymatic activities.
  3. Static Glycan Structure Analyses:
    Studies that primarily focus on the static structural analysis of glycans without functional or dynamic context are becoming less frequent, indicating a trend towards understanding glycan behavior in live systems.
  4. Glycoconjugates in Non-Medical Applications:
    Research on glycoconjugates in areas outside of medical applications, such as agriculture or environmental studies, appears to be less frequent, which may reflect a narrowing of the journal's focus towards health-related research.

Similar Journals

Cell Discovery

Advancing the Frontiers of Cellular Science
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

Genes & Diseases

Advancing knowledge at the intersection of genetics and disease.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

BIOLOGY OF THE CELL

Unveiling the secrets of life, one cell at a time.
Publisher: WILEYISSN: 0248-4900Frequency: 12 issues/year

BIOLOGY OF THE CELL is a prominent academic journal published by Wiley, dedicated to advancing the field of cellular biology through the dissemination of innovative research and insights. With its ISSN (0248-4900) and E-ISSN (1768-322X), this journal has been a vital resource since its inception in 1981 and is set to continue its scholarly contributions until 2024. Positioned within the Q3 quartile in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, BIOLOGY OF THE CELL is recognized for its rigorous peer-review process and its commitment to high-quality publication in critical areas such as biochemistry, genetics, and molecular biology. Although the journal does not currently offer open access options, it remains accessible through the Wiley platform, ensuring that researchers, professionals, and students can benefit from its rich repository of knowledge. By linking fundamental cellular processes with broader medical implications, this journal serves as a critical platform for fostering dialogue and innovation in cellular research, making it an essential read for anyone engaged in the life sciences.

Biochemistry Moscow Supplement Series A-Membrane and Cell Biology

Navigating the Evolving Landscape of Biochemistry
Publisher: PLEIADES PUBLISHING INCISSN: 1990-7478Frequency: 4 issues/year

Biochemistry Moscow Supplement Series A-Membrane and Cell Biology, published by PLEIADES PUBLISHING INC in the United States, is a pivotal journal in the fields of biochemistry, biophysics, and cell biology. Established in 2008, this journal has become a significant platform for disseminating novel research findings and reviews, fostering advanced studies in membrane dynamics and cellular processes. Although currently ranked in the Q4 quartile across its categories, the journal provides researchers and professionals with open access to a wealth of knowledge, helping to bridge gaps in understanding complex biochemical mechanisms. The journal’s commitment to quality and relevance is evident as it continues to contribute to the academic community through its coverage of innovative and emerging topics in cell and membrane biology. Researchers, practitioners, and students alike will find this resource invaluable for keeping abreast of the latest developments in the ever-evolving landscape of biochemistry and cellular research.

CELLULAR AND MOLECULAR BIOLOGY

Advancing the Frontiers of Life Sciences
Publisher: C M B ASSOCISSN: 0145-5680Frequency: 8 issues/year

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Elevating discourse in biochemistry and biophysics.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0006-291XFrequency: 52 issues/year

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

GLYCOBIOLOGY

Connecting Biochemistry and Health through Glycans
Publisher: OXFORD UNIV PRESS INCISSN: 0959-6658Frequency: 12 issues/year

GLYCOBIOLOGY is a premier journal published by Oxford University Press Inc., focusing on the multidisciplinary field of glycoscience. With an ISSN of 0959-6658 and an E-ISSN of 1460-2423, this journal has established itself as an essential resource for researchers, professionals, and students interested in the biochemical aspects of glycan structures, functions, and interactions. The journal boasts a Q1 rank in the biochemistry category for 2023, placing it in the top-tier of scholarly publications, and achieving a percentile rank of 71st out of 438 in the Scopus database for biochemistry, genetics, and molecular biology. Covering integral aspects of glycobiology since its inception in 1990, GLYCOBIOLOGY offers a robust platform for the dissemination of novel research findings, reviews, and methodologies that advance the understanding of glycan-related processes and their implications in health and disease. Researchers can access high-quality content that not only promotes scientific discourse but also pushes the boundaries of knowledge in this vital field.

CELL STRESS & CHAPERONES

Elevating Research on Protein Dynamics and Health
Publisher: SPRINGERISSN: 1355-8145Frequency: 4 issues/year

CELL STRESS & CHAPERONES is a renowned journal that has been at the forefront of advancing our understanding of protein folding, cellular stress responses, and the role of chaperone proteins since its inception in 1996. Published by SPRINGER, this esteemed journal operates out of the Netherlands and serves as a critical platform for researchers in the fields of Biochemistry and Cell Biology. With an impressive impact factor reflecting its credibility—ranked Q2 in Biochemistry and Q3 in Cell Biology for 2023—it showcases rigorous, peer-reviewed research that contributes significantly to the understanding of cellular mechanisms and their implications in health and disease. The journal's commitment to disseminating high-quality research is evident through its indexed status ranking in the Scopus database, identifying it among the top quartile of publications in its respective categories. For scholars and practitioners dedicated to exploring the intricate relationship between cellular stress and physiological responses, CELL STRESS & CHAPERONES provides a vital resource, fostering an interdisciplinary dialogue that enhances the scientific community's collective knowledge.

FEBS Open Bio

Empowering the scientific community with groundbreaking knowledge.
Publisher: WILEYISSN: 2211-5463Frequency: 1 issue/year

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

JOURNAL OF DERMATOLOGICAL SCIENCE

Shaping Tomorrow's Dermatological Discoveries
Publisher: ELSEVIER IRELAND LTDISSN: 0923-1811Frequency: 12 issues/year

The Journal of Dermatological Science is a premier peer-reviewed publication dedicated to advancing knowledge in the field of dermatology, biochemistry, and molecular biology. Established in 1990 and published by Elsevier Ireland Ltd, this esteemed journal has consistently achieved high academic recognition, securing a Q1 ranking in Dermatology and a Q2 ranking in both Biochemistry and Molecular Biology as of 2023. With a notable impact factor and a Scopus rank that places it within the top tier of dermatology journals globally, it serves as a critical platform for researchers, clinicians, and academicians to disseminate their findings and foster innovation in skin health and disease management. Although the journal is not open access, it provides essential insights into cutting-edge research, clinical practices, and molecular mechanisms underlying dermatological conditions. The Journal of Dermatological Science is not only a vital resource for high-quality articles but also a driving force in shaping the future landscape of dermatological research.